Most started01 / 06
Weight care
Weekly GLP-1 injections (semaglutide or tirzepatide) prescribed and adjusted by your provider.
From $149/mo
Explore weight care
Concierge telehealth for women. Weight, skin, hair, hormones and intimacy, in one place, with a provider who knows your name.
Find my treatment How it worksWeekly GLP-1 injections (semaglutide or tirzepatide) prescribed and adjusted by your provider.
Daily semaglutide tablets for women who would rather skip the needle.
A custom prescription tretinoin formula for breakouts, texture and tone.
Prescription minoxidil regrowth, checked at three and six months.
Estradiol and progesterone care for perimenopause and menopause.
Private prescription care for desire, comfort and connection.
Shown for illustration. Prescription only. A licensed provider decides whether treatment is right for you.
Weight care
GLP-1 tablets
Skin
Hair
Hormones
Intimacy
Tirzepatide
2 of 6Two minutes on our questionnaire, no account needed, to find the program that fits.
A private, secure intake with your history, medications and a photo ID check.
A clinician licensed in your state reviews everything, prescribes if appropriate, and stays with you by message.
Your prescription is dispensed by a licensed pharmacy and shipped discreetly, with refills on schedule.
You answer a private medical intake. A provider licensed in your state decides what is right for you, prescribes if appropriate, and stays with you by secure message. No call centre, no scripts.
BMI is one of the first things a provider looks at when considering GLP-1 care. It is a starting point for the conversation, never a verdict on you.
These results come from large clinical trials of FDA-approved branded medications. They are not BellaHealth. patient outcomes, and compounded versions were not studied in these trials.
Average body-weight reduction at 72 weeks on the highest tirzepatide dose, versus 3.1% on placebo, alongside diet and activity changes. SURMOUNT-1, NEJM 2022.
Average body-weight reduction at 68 weeks on weekly semaglutide 2.4 mg, versus 2.4% on placebo. STEP 1, NEJM 2021.
Lower risk of major cardiovascular events with semaglutide in adults with overweight or obesity and existing heart disease. SELECT, NEJM 2023.
Individual results vary. Common side effects include nausea, diarrhea and constipation. A provider decides whether treatment is appropriate for you.
One provider across weight, skin, hair, hormones and intimacy. Turn the sound on.
See which BellaHealth. program fits you, then meet your provider.
Find my treatmentJoin the BellaHealth. list and your first-visit credit is applied automatically when we open in your state.
No spam. Unsubscribe any time.